組織銀行市場——COVID-19 的增長、趨勢、影響和預測 (2023-2028)
市場調查報告書
商品編碼
1273494

組織銀行市場——COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Tissue Banking Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內,組織庫市場預計將以 5.9% 的複合年增長率增長。

COVID-19 的突然出現對所研究的市場產生了重大影響。 根據各種研究,在 COVID-19 大流行早期減少外科手術導致組織分佈顯著減少。 此外,在早期,世界各國報告組織捐獻者的數量普遍下降。 由於選擇性手術的停止,組織變得稀缺,可用組織被保留用於緊急手術干預和醫療程序。 這些都對研究市場產生了負面影響。

然而,隨之而來的大流行激發了乾細胞研究,以尋找一種有效的抗 COVID-19 感染疫苗。 例如,根據 2022 年 1 月發表在《幹細胞研究與治療》雜誌上的一篇研究文章,細胞療法在多種疾病中都有重要的應用,包括肺部、心血管、肝臟、腎臟等疾病,它是一種治愈方法。 因此,他們有望找到治愈 COVID-19 的方法。 此外,如上述來源所述,幹細胞療法和乾細胞衍生的類器官模型作為 COVID-19 的新治療和研究方法受到了廣泛關注。 因此,此類實例表明,大流行對市場的增長產生了相當大的影響,預計在預測期內這種情況將持續下去。

不斷上升的醫療保健成本、不斷增加的慢性病負擔以及藥物發現和開發方面的技術進步是組織庫市場的主要驅動力。 例如,根據世衛組織 2022 年 9 月的更新,慢性病仍然是一項巨大的全球挑戰,佔 2021 年全球所有死亡人數的 74% 左右。 此外,根據 IDF 2021 年 9 月的更新,到 2021 年將有約 5.37 億成年人(20-79 歲)患有糖尿病,到 2030 年將有約 6.43 億人。預計到 2045 年將有約 7.83 億人患有糖尿病.

此外,根據全球癌症觀察站於 2021 年 3 月更新的數據,2020 年約有 1930 萬男性和女性新診斷出患有癌症。 報告稱,全球癌症發病率正在迅速上升,並估計到 2040 年,男性和女性將有大約 3020 萬新發癌症病例。 這樣,隨著慢性病的增加,組織庫的需求預計會增加,因為組織通常用於疾病研究活動、疾病的診斷和治療。 因此,預計這些因素將在預測期內推動組織銀行市場的增長。

但是,預計嚴格的監管情景將阻礙預測期內的市場增長。

組織庫市場趨勢

預計醫學研究部門在預測期內將增長

通常開展基於組織的醫學研究是為了擴展我們對人類生物學的了解,並幫助開發疾病診斷技術、未來治療方法和治療方案。 基於組織的研究還有助於快速開發更有效和更安全的藥物,並更好地了解影響人類的疾病的潛在過程。 人體組織是醫學研究最有效的組織。 它通常是從捐獻者死後的手術殘渣、血液或其他體液中獲得的。 因此,預計醫學研究領域的增長將推動分析期間的增長。

在醫學研究中,組織利用率的提高和組織覆蓋範圍的擴大是該領域增長的主要驅動力之一。 例如,根據責任醫學醫師委員會 2022 年 5 月發表的一篇文章,在科學研究中使用人體組織正在導致疾病進展、藥物開發和醫療程序方面的發現,從而改善醫療保健。 器官芯片、3D 生物打印和其他使用人體組織而不是動物的方法提供的結果更能反映人類健康。

上述消息來源表明,人體組織目前用於研究癌症、心髒病、糖尿病、阿爾茨海默病和其他癡呆症等病症和疾病,以及治療帕金森病和多發性硬化症等病症。據報導,用於生物醫學研究的許多領域。 人體組織也用於毒理學測試的微流體系統和檢測生物或化學危害的生物傳感器。 因此,隨著醫學研究變得更加活躍,對組織庫的需求也在增加。 預計這將進一步推動該細分市場的增長。

組織銀行市場-IMG1

預計北美將佔據很大的市場份額

在預測期內,預計北美將主導整個組織庫市場。 這種增長是由於研究活動的增加、慢性病的增加以及北美地區製藥公司的增加等因素造成的。

由於組織庫篩選捐贈者、檢索、處理、儲存和/或分發同種異體移植組織,慢性病中心髒病的患病率不斷增加,這增加了美國對組織庫的需求。正在生產。 根據疾病預防控制中心 2022 年 7 月的更新,心髒病在美國人口中很常見,2020 年冠心病影響了大約 2010 萬 20 歲及以上的成年人,是最常見的一種心髒病。

此外,根據加拿大政府2021年8月發布的一份報告,2020年將有超過300萬加拿大人,即8.8%的人口被診斷出患有糖尿病,6.1%的加拿大成年人將被診斷出患有糖尿病未來糖尿病。據說這一年患糖尿病的風險很高。 該報告還報告說,加拿大糖尿病患病率的上升以及 COVID-19 對糖尿病患者的負面影響強調了繼續投資於糖尿病研究、治療和預防的重要性。。 因此,這種情況有望推動北美市場的增長。

主要產品的發布、市場參與者和製造商的高度集中、主要參與者之間的收購和合作夥伴關係是推動該國組織庫市場增長的一些因素。 此外,政府機構正在大力投資各種組織庫項目,這進一步推動了市場的增長。

例如,2021 年 10 月,美國國家人類基因組研究所計劃在五年內撥款 3850 萬美元用於發育基因型-組織表達 (dGTEx) 項目,以擴大現有基因表達資源,將發育組織納入其中。 這個項目旨在創建一個廣泛可用的組織庫和數據庫,其中包含許多兒科組織類型中人類發育基因表達的信息,用於美國的基礎和臨床研究。我正在做。 預計此類投資將有助於該地區的整體市場增長。 因此,由於投資增加和各種疾病的流行,預計北美市場將擴大。

組織銀行市場-IMG2

組織銀行行業概覽

組織庫市場競爭激烈,由各種全球和區域市場參與者組成。 競爭格局包括 AMS Biotechnology (Europe) Limited、Avantor, Inc (VWR International)、BioCision LLC、Brooks Automation、Custom Biogenic Systems、Eppendorf AG、Hamilton Company、Merck KGaA、Thermo Fisher Scientific, Inc。簡介國際和本地公司。

其他福利:

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 醫療支出增加
    • 慢性病負擔加重
    • 藥物發現和開發方面的技術進步
  • 市場製約因素
    • 嚴格的監管場景
  • 波特五力
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按產品分類
    • 設備
      • 低溫保存裝置
      • 除霜裝置
      • 質量控制設備
      • 其他
    • 媒體和消耗品
  • 通過使用
    • 治療藥物
    • 用於醫學研究
    • 其他用途
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Rokit Healthcare Inc.
    • AMS Biotechnology(Europe)Limited
    • Avantor, Inc(VWR International)
    • Sartorius AG
    • Azenta Life Sciences
    • Bio-Rad Laboratories Inc.
    • Eppendorf AG
    • Hamilton Company
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • LifeLink Tissue Bank
    • BioLife Solutions

第七章市場機會與未來趨勢

簡介目錄
Product Code: 67747

The tissue banking market is expected to register a CAGR of 5.9% over the forecast period.

The sudden emergence of COVID-19 had a significant impact on the market studied. According to various research studies, tissue distribution has been greatly reduced because of the decrease in surgical activity in the initial days of the COVID-19 pandemic. It was also reported that during the very initial period, a general drop in the number of tissue donors had been observed in various countries globally. Due to the cancellation of elective operations, there was a scarcity of tissues, and the available tissues were only utilized in urgent surgical interventions or medical procedures. These impacted the studied market adversely.

However, during the later pandemic, the trend for stem cell research increased to find effective vaccines for COVID-19 infection. For instance, according to a research article published in the Stem Cell Research and Therapy journal in January 2022, cell therapy is a significant treatment applied in several diseases, including lung, cardiovascular, liver, kidney, and other diseases. Thus these are anticipated to find a cure for COVID-19. Also, as per the source above, stem cell therapy and stem cell-derived organoid models received huge attention as a new treatment and research method for COVID-19. Therefore, such instances indicate that the pandemic had a considerable impact on the market growth, and it is expected to continue its growth over the forecast period.

The rising healthcare expenditure, the growing burden of chronic diseases, and technological advances in drug discovery and development are the major drivers for the tissue banking market. For instance, according to September 2022 update by WHO, chronic diseases have always been a massive global challenge, and they accounted for approximately 74% of all deaths worldwide in 2021. Furthermore, according to the September 2021 update by IDF, around 537.0 million adults (20-79 years) were living with diabetes in 2021, and around 643 million and 783 million people are expected to live with diabetes by 2030 and 2045, respectively.

In addition, as per the Global Cancer Observatory data updated in March 2021, nearly 19.3 million new cases of cancer were diagnosed in 2020 globally among both men and women. The same source reported that the incidence of cancer was growing at a rapid pace in the world and estimated that the number of new cases of cancer in both sexes is projected to reach around 30.2 million by 2040. Thus, with the increasing number of chronic diseases, the demand for tissue banks is anticipated to increase as tissues are generally used in research activities related to diseases and the diagnosis and treatment of diseases. Therefore, such factors are anticipated to propel the tissue banking market growth over the forecast period.

However, a stringent regulatory scenario is expected to hinder market growth over the forecast period.

Tissue Banking Market Trends

Medical Research Segment is Expected to Witness Growth Over the Forecast Period

Medical research using tissues generally helps to expand knowledge regarding human biology and helps to develop disease diagnosis techniques, future therapies, and treatment protocols. In addition, conducting research using tissues enables the faster development of more effective, safer drugs and a better understanding of the underlying disease processes that affect humans. Human tissues are the most effective tissues for medical research. They are typically obtained from post-mortem of people who are organ donors, as leftovers from surgery, and through blood or other body fluids. Thus, owing to the increase in the medical research segment, growth is expected over the analysis period.

The increasing use of tissues and the wide applicability of tissues in medical research is one of the key drivers for segment growth. For instance, according to an article published by the Physicians Committee for Responsible Medicine in May 2022, the use of human tissues in scientific research has improved health care by leading to discoveries in disease progression, drug development, and medical procedures. Organs on chips, 3D bioprinting, and other methods that use human tissue instead of animals provide results that translate better to human health.

The source above also reported that human tissues are currently used in many areas of biomedical research, including research on conditions and diseases such as cancer, heart disease, diabetes, Alzheimer's disease, and other dementias, and for the treatment of conditions such as Parkinson's disease and multiple sclerosis. Human tissue is also used in microfluidic systems for toxicology testing and as biosensors for detecting biological or chemical hazards. Thus, owing to the upsurge in medical research, the demand for tissue banking is increasing. This is further expected to fuel the segment's growth.

Tissue Banking Market - IMG1

North America is Expected to Hold a Significant Share of the Market

North America is expected to dominate the overall tissue banking market over the forecast period. The growth is due to factors such as increasing research activities, a rise in chronic diseases, and an increasing number of pharmaceutical companies in the North American region.

As tissue banks provide donor screening, recovery, processing, storage, and/or distribution of allograft tissue, the increasing prevalence of heart diseases among chronic diseases is creating demand for tissue banks in the United States. According to the July 2022 update by CDC, heart disease is common among the population of the United States, and coronary heart disease was the most common type of heart disease which affected nearly 20.1 million adults aged 20 or above in 2020.

In addition, according to the report published by the Government of Canada in August 2021, more than 3.0 million Canadians, or 8.8% of the population were diagnosed with diabetes in 2020, and 6.1% of Canadian adults are at high risk of developing diabetes in the upcoming years. It also reported that the increasing prevalence of diabetes in Canada and the negative impacts of COVID-19 on people with diabetes have underscored the importance of continued investment in diabetes research, treatment, and prevention. Therefore, such a scenario is expected to propel market growth in North America.

Key product launches, high concentration of market players or manufacturers, acquisitions, and partnerships among major players are among the factors driving the growth of the tissue banking market in the country. Additionally, government organizations are heavily investing in various tissue-banking projects, which is further fueling the market growth.

For instance, in October 2021, the National Human Genome Research Institute planned to expand existing gene expression resources to include developmental tissues by awarding USD 38.5 million over five years to the Developmental Genotype-Tissue Expression (dGTEx) project. This project aims to build a widely available tissue bank and database with information about human developmental gene expression in many types of tissues from children for use in basic and clinical research in the United States. Such investments are expected to contribute to the overall, market growth in the region. Therefore, owing to increasing investments and the prevalence of various diseases, the studied market is anticipated to witness growth in North America.

Tissue Banking Market - IMG2

Tissue Banking Industry Overview

The tissue banking market is competitive in nature and consists of various global and regional market players. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known, including AMS Biotechnology (Europe) Limited, Avantor, Inc (VWR International), BioCision LLC, Brooks Automation, Custom Biogenic Systems, Eppendorf AG, Hamilton Company, Merck KGaA, and Thermo Fisher Scientific, Inc. among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Defination
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Healthcare Expenditure
    • 4.2.2 Growing Burden of Chronic Diseases
    • 4.2.3 Technological Advances in Drug Discovery and Development
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Scenario
  • 4.4 Porter Five Forces
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Equipment
      • 5.1.1.1 Cryopreservation Equipment
      • 5.1.1.2 Thawing Equipment
      • 5.1.1.3 Quality Control Equipment
      • 5.1.1.4 Others
    • 5.1.2 Media and Consumables
  • 5.2 By Application
    • 5.2.1 Therapeutics
    • 5.2.2 Medical Research
    • 5.2.3 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Rokit Healthcare Inc.
    • 6.1.2 AMS Biotechnology (Europe) Limited
    • 6.1.3 Avantor, Inc (VWR International)
    • 6.1.4 Sartorius AG
    • 6.1.5 Azenta Life Sciences
    • 6.1.6 Bio-Rad Laboratories Inc.
    • 6.1.7 Eppendorf AG
    • 6.1.8 Hamilton Company
    • 6.1.9 Merck KGaA
    • 6.1.10 Thermo Fisher Scientific, Inc.
    • 6.1.11 LifeLink Tissue Bank
    • 6.1.12 BioLife Solutions

7 MARKET OPPORTUNITIES AND FUTURE TRENDS